Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

NCT02312622 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Non-small Cell Lung Cancer (NSCLC)
Recurrent Non-small Cell Lung Cancer (NSCLC)
Extensive-stage Small Cell Lung Cancer (SCLC)
Recurrent Small Cell Lung Cancer (SCLC)
Tumors Metastatic to Brain
Metastatic Breast Cancer (mBC)

Interventions

DRUG: Pegylated Irinotecan

Sponsor

Joel Neal

Collaborators

[object Object]